UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide

Pharmaceutical research, 2019-03, Vol.36 (3), p.49-14, Article 49

2019

Volltextzugriff (PDF)

Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec

Nature communications, 2024-07, Vol.15 (1), p.6124-11, Article 6124

2024

Volltextzugriff (PDF)

One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2004-05, Vol.53 (5), p.1187-1194

2004

Volltextzugriff (PDF)

A novel high-affinity peptide antagonist to the insulin receptor

Biochemical and biophysical research communications, 2008-11, Vol.376 (2), p.380-383

2008

Volltextzugriff (PDF)

Small-molecule agonists for the glucagon-like peptide 1 receptor

Proceedings of the National Academy of Sciences - PNAS, 2007-01, Vol.104 (3), p.937-942

2007

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

Diabetes care, 2002-08, Vol.25 (8), p.1398-1404

2002

Volltextzugriff (PDF)

Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

Diabetes (New York, N.Y.), 2002-02, Vol.51 (2), p.424-429

2002

Volltextzugriff (PDF)

The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose

Diabetes (New York, N.Y.), 2003-07, Vol.52 (7), p.1786-1791

2003

Volltextzugriff (PDF)

Probing the mechanism of reduced in vivo potency of insulin detemir

Expert opinion on drug metabolism & toxicology, 2023-04, Vol.19 (4), p.225-228

2023

Volltextzugriff (PDF)

Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5

Diabetes technology & therapeutics, 2022-01, Vol.24 (1), p.10-17

2022

Volltextzugriff (PDF)

Commemorating insulin's centennial: engineering insulin pharmacology towards physiology

Trends in pharmacological sciences (Regular ed.), 2021-08, Vol.42 (8), p.620-639

2021

Volltextzugriff (PDF)

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

Diabetes (New York, N.Y.), 1992-03, Vol.41 (3), p.368-377

1992

Volltextzugriff (PDF)

815-P: Enhanced Disulphide Bond Stability Contributes to the Once Weekly PD Profile of Insulin Icodec

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat

Diabetes (New York, N.Y.), 2003-10, Vol.52 (10), p.2513-2518

2003

Volltextzugriff (PDF)

381-P: Recurrent Hypoglycemia Alters Endocrine Counterregulation during Insulin-Induced Hypoglycemia in Healthy and Diabetic Göttingen Minipigs

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Improved β-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a β-Cell–Selective KATP Channel Opener

Diabetes (New York, N.Y.), 2004-04, Vol.53 (4), p.1089-1095

2004

Volltextzugriff (PDF)

Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review

Journal of diabetes science and technology, 2023-03, Vol.17 (2), p.290-301

2023

Volltextzugriff (PDF)

Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog

Computer methods and programs in biomedicine, 2021-06, Vol.205, p.106087-106087, Article 106087

2021

Volltextzugriff (PDF)

Sleepiness, Performance, and Neuroendocrine Function during Sleep Deprivation: Effects of Exposure to Bright Light or Exercise

Journal of biological rhythms, 1997-06, Vol.12 (3), p.245-258

1997

Volltextzugriff (PDF)

Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed TM 670G hybrid closed-loop system in simulated trials compared to NovoLog

Computer methods and programs in biomedicine, 2021-06, Vol.205, p.106087

2021

Volltextzugriff (PDF)

Glucose- and Interleukin-1β-Induced β-Cell Apoptosis Requires Ca2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/Kir6.2) Selective Potassium Channel Opener in Human Islets

Diabetes (New York, N.Y.), 2004-07, Vol.53 (7), p.1706-1713

2004

Volltextzugriff (PDF)

GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics

British journal of pharmacology, 2003-09, Vol.140 (1), p.123-132

2003

Volltextzugriff (PDF)

Temporal profiles and clinical significance of pulsatile insulin secretion

Hormone research, 1998-01, Vol.49 (3-4), p.178-184

1998

Volltextzugriff (PDF)

Comparison of the pharmacokinetics of three concentrations of insulin aspart during continuous subcutaneous insulin infusion (CSII) in a pig model

Journal of pharmacy and pharmacology, 2013-02, Vol.65 (2), p.230-235

2013

Volltextzugriff (PDF)

Modeling the Insulin–Glucose Feedback System: The Significance of Pulsatile Insulin Secretion

Journal of theoretical biology, 2000-12, Vol.207 (3), p.361-375

2000

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Biological And Medical Sciences
(49)
Humans
(46)
Life Sciences & Biomedicine
(43)
Male
(40)
Insulin - Metabolism
(38)
Medical Sciences
(38)
Insulin Secretion
(37)
Adult
(28)
Endocrinology & Metabolism
(28)
Female
(27)
Insulin
(25)
Insulin - Blood
(24)
Endocrinopathies
(23)
Diabetes. Impaired Glucose Tolerance
(22)
Endocrine Pancreas. Apud Cells
(22)
Blood Glucose - Metabolism
(21)
Diabetes
(21)
Animals
(18)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide

Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec

One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

A novel high-affinity peptide antagonist to the insulin receptor

Small-molecule agonists for the glucagon-like peptide 1 receptor

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose

Probing the mechanism of reduced in vivo potency of insulin detemir

Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5

Commemorating insulin's centennial: engineering insulin pharmacology towards physiology

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

815-P: Enhanced Disulphide Bond Stability Contributes to the Once Weekly PD Profile of Insulin Icodec

NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat

381-P: Recurrent Hypoglycemia Alters Endocrine Counterregulation during Insulin-Induced Hypoglycemia in Healthy and Diabetic Göttingen Minipigs

Improved β-Cell Survival and Reduced Insulitis in a Type 1 Diabetic Rat Model After Treatment With a β-Cell–Selective KATP Channel Opener

Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review

Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog

Sleepiness, Performance, and Neuroendocrine Function during Sleep Deprivation: Effects of Exposure to Bright Light or Exercise

Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed TM 670G hybrid closed-loop system in simulated trials compared to NovoLog

Glucose- and Interleukin-1β-Induced β-Cell Apoptosis Requires Ca2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/Kir6.2) Selective Potassium Channel Opener in Human Islets

GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics

Temporal profiles and clinical significance of pulsatile insulin secretion

Comparison of the pharmacokinetics of three concentrations of insulin aspart during continuous subcutaneous insulin infusion (CSII) in a pig model

Modeling the Insulin–Glucose Feedback System: The Significance of Pulsatile Insulin Secretion

Suchergebnisse filtern